Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

From bed to bench side: Reverse translation to optimize neuromodulation for mood disorders.

Rudebeck PH, Rich EL, Mayberg HS.

Proc Natl Acad Sci U S A. 2019 Dec 23. pii: 201902287. doi: 10.1073/pnas.1902287116. [Epub ahead of print]

2.

Somatic symptoms in treatment-naïve Hispanic and non-Hispanic patients with major depression.

Dunlop BW, Still S, LoParo D, Aponte-Rivera V, Johnson BN, Schneider RL, Nemeroff CB, Mayberg HS, Craighead WE.

Depress Anxiety. 2019 Dec 12. doi: 10.1002/da.22984. [Epub ahead of print]

PMID:
31830355
3.

Cingulate-mediated depressive symptoms in neurologic disease and therapeutics.

Riva-Posse P, Holtzheimer PE, Mayberg HS.

Handb Clin Neurol. 2019;166:371-379. doi: 10.1016/B978-0-444-64196-0.00021-2.

PMID:
31731923
4.

Investigation of MORC1 DNA methylation as biomarker of early life stress and depressive symptoms.

Thomas M, Coope A, Falkenberg C, Dunlop BW, Czamara D, Provencal N, Craighead WE, Mayberg HS, Nemeroff CB, Binder EB, Nieratschker V.

J Psychiatr Res. 2020 Jan;120:154-162. doi: 10.1016/j.jpsychires.2019.10.019. Epub 2019 Oct 26.

PMID:
31683097
5.

Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression.

Crowell AL, Riva-Posse P, Holtzheimer PE, Garlow SJ, Kelley ME, Gross RE, Denison L, Quinn S, Mayberg HS.

Am J Psychiatry. 2019 Nov 1;176(11):949-956. doi: 10.1176/appi.ajp.2019.18121427. Epub 2019 Oct 4.

PMID:
31581800
6.

Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics.

Ramirez-Zamora A, Giordano J, Boyden ES, Gradinaru V, Gunduz A, Starr PA, Sheth SA, McIntyre CC, Fox MD, Vitek J, Vedam-Mai V, Akbar U, Almeida L, Bronte-Stewart HM, Mayberg HS, Pouratian N, Gittis AH, Singer AC, Creed MC, Lazaro-Munoz G, Richardson M, Rossi MA, Cendejas-Zaragoza L, D'Haese PF, Chiong W, Gilron R, Chizeck H, Ko A, Baker KB, Wagenaar J, Harel N, Deeb W, Foote KD, Okun MS.

Front Neurosci. 2019 Sep 12;13:936. doi: 10.3389/fnins.2019.00936. eCollection 2019.

7.

Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment.

Bhattacharyya S, Dunlop BW, Mahmoudiandehkordi S, Ahmed AT, Louie G, Frye MA, Weinshilboum RM, Krishnan RR, Rush AJ, Mayberg HS, Craighead WE, Kaddurah-Daouk R.

Front Neurosci. 2019 Sep 12;13:926. doi: 10.3389/fnins.2019.00926. eCollection 2019.

8.

Neuroanatomical predictors of response to subcallosal cingulate deep brain stimulation for treatment-resistant depression

Sankar T, Chakravarty MM, Jawa N, Li SX, Giacobbe P, Kennedy SH, Rizvi SJ, Mayberg HS, Hamani C, Lozano AM.

J Psychiatry Neurosci. 2020 Jan 1;45(1):45-54. doi: 10.1503/jpn.180207.

9.

A difference degree test for comparing brain networks.

Higgins IA, Kundu S, Choi KS, Mayberg HS, Guo Y.

Hum Brain Mapp. 2019 Oct 15;40(15):4518-4536. doi: 10.1002/hbm.24718. Epub 2019 Jul 26.

PMID:
31350786
10.

Field potential 1/f activity in the subcallosal cingulate region as a candidate signal for monitoring deep brain stimulation for treatment-resistant depression.

Veerakumar A, Tiruvadi V, Howell B, Waters AC, Crowell AL, Voytek B, Riva-Posse P, Denison L, Rajendra JK, Edwards JA, Bijanki KR, Choi KS, Mayberg HS.

J Neurophysiol. 2019 Sep 1;122(3):1023-1035. doi: 10.1152/jn.00875.2018. Epub 2019 Jul 17.

PMID:
31314668
11.

Recall accuracy for the symptoms of a major depressive episode among clinical trial participants.

Dunlop BW, Granros M, Lechner A, Mletzko-Crowe T, Nemeroff CB, Mayberg HS, Craighead WE.

J Psychiatr Res. 2019 Sep;116:178-184. doi: 10.1016/j.jpsychires.2019.03.008. Epub 2019 Mar 8.

PMID:
30878146
12.

Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.

Jovanovic T, Duncan EJ, Kaye J, Garza K, Norrholm SD, Inslicht SS, Neylan TC, Mathew SJ, Iosifescu D, Rothbaum BO, Mayberg HS, Dunlop BW.

Psychophysiology. 2020 Jan;57(1):e13356. doi: 10.1111/psyp.13356. Epub 2019 Feb 26.

PMID:
30807663
13.

Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.

Dunlop BW, LoParo D, Kinkead B, Mletzko-Crowe T, Cole SP, Nemeroff CB, Mayberg HS, Craighead WE.

Am J Psychiatry. 2019 Apr 1;176(4):275-286. doi: 10.1176/appi.ajp.2018.18091075. Epub 2019 Feb 15.

14.

Autonomic arousal elicited by subcallosal cingulate stimulation is explained by white matter connectivity.

Riva-Posse P, Inman CS, Choi KS, Crowell AL, Gross RE, Hamann S, Mayberg HS.

Brain Stimul. 2019 May - Jun;12(3):743-751. doi: 10.1016/j.brs.2019.01.015. Epub 2019 Jan 26.

PMID:
30738778
15.

Cingulum stimulation enhances positive affect and anxiolysis to facilitate awake craniotomy.

Bijanki KR, Manns JR, Inman CS, Choi KS, Harati S, Pedersen NP, Drane DL, Waters AC, Fasano RE, Mayberg HS, Willie JT.

J Clin Invest. 2019 Mar 1;129(3):1152-1166. doi: 10.1172/JCI120110. Epub 2019 Feb 11.

16.

DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder.

Pape JC, Carrillo-Roa T, Rothbaum BO, Nemeroff CB, Czamara D, Zannas AS, Iosifescu D, Mathew SJ, Neylan TC, Mayberg HS, Dunlop BW, Binder EB.

Clin Epigenetics. 2018 Nov 3;10(1):136. doi: 10.1186/s13148-018-0569-x.

17.

Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects.

Li M, Woelfer M, Colic L, Safron A, Chang C, Heinze HJ, Speck O, Mayberg HS, Biswal BB, Salvadore G, Fejtova A, Walter M.

Eur Arch Psychiatry Clin Neurosci. 2018 Oct 23. doi: 10.1007/s00406-018-0942-y. [Epub ahead of print]

PMID:
30353262
18.

Quantifying the axonal pathways directly stimulated in therapeutic subcallosal cingulate deep brain stimulation.

Howell B, Choi KS, Gunalan K, Rajendra J, Mayberg HS, McIntyre CC.

Hum Brain Mapp. 2019 Feb 15;40(3):889-903. doi: 10.1002/hbm.24419. Epub 2018 Oct 11.

19.

Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse.

Kelley ME, Dunlop BW, Nemeroff CB, Lori A, Carrillo-Roa T, Binder EB, Kutner MH, Rivera VA, Craighead WE, Mayberg HS.

Depress Anxiety. 2018 Oct;35(10):992-1000. doi: 10.1002/da.22832. Epub 2018 Sep 7.

20.

Neuroimaging Advances for Depression.

Dunlop BW, Mayberg HS.

Cerebrum. 2017 Nov 1;2017. pii: cer-16-17. eCollection 2017 Nov-Dec.

21.

Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder.

Dunlop BW, Polychroniou PE, Rakofsky JJ, Nemeroff CB, Craighead WE, Mayberg HS.

Psychol Med. 2019 Aug;49(11):1869-1878. doi: 10.1017/S0033291718002568. Epub 2018 Sep 12.

PMID:
30207254
22.

Defective Inflammatory Pathways in Never-Treated Depressed Patients Are Associated with Poor Treatment Response.

Syed SA, Beurel E, Loewenstein DA, Lowell JA, Craighead WE, Dunlop BW, Mayberg HS, Dhabhar F, Dietrich WD, Keane RW, de Rivero Vaccari JP, Nemeroff CB.

Neuron. 2018 Sep 5;99(5):914-924.e3. doi: 10.1016/j.neuron.2018.08.001. Epub 2018 Aug 23.

23.

Test-retest reliability of a stimulation-locked evoked response to deep brain stimulation in subcallosal cingulate for treatment resistant depression.

Waters AC, Veerakumar A, Choi KS, Howell B, Tiruvadi V, Bijanki KR, Crowell A, Riva-Posse P, Mayberg HS.

Hum Brain Mapp. 2018 Dec;39(12):4844-4856. doi: 10.1002/hbm.24327. Epub 2018 Aug 18.

24.

Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Naïve Depressed Adults.

Polychroniou PE, Mayberg HS, Craighead WE, Rakofsky JJ, Aponte Rivera V, Haroon E, Dunlop BW.

Behav Sci (Basel). 2018 Jul 17;8(7). pii: E64. doi: 10.3390/bs8070064.

25.

Initial Unilateral Exposure to Deep Brain Stimulation in Treatment-Resistant Depression Patients Alters Spectral Power in the Subcallosal Cingulate.

Smart O, Choi KS, Riva-Posse P, Tiruvadi V, Rajendra J, Waters AC, Crowell AL, Edwards J, Gross RE, Mayberg HS.

Front Comput Neurosci. 2018 Jun 12;12:43. doi: 10.3389/fncom.2018.00043. eCollection 2018.

26.

Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders.

Ahmed AT, Frye MA, Rush AJ, Biernacka JM, Craighead WE, McDonald WM, Bobo WV, Riva-Posse P, Tye SJ, Mayberg HS, Hall-Flavin DK, Skime MK, Jenkins GD, Wang L, Krishnan RR, Weinshilboum RM, Kaddurah-Daouk R, Dunlop BW; Mood Disorders Precision Medicine Consortium (MDPMC).

J Affect Disord. 2018 Oct 1;238:1-7. doi: 10.1016/j.jad.2018.05.005. Epub 2018 May 26.

27.

Can a Framework Be Established for the Safe Use of Ketamine?

Freedman R, Brown AS, Cannon TD, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, Rush AJ, Tamminga CA, Tohen M, Vieta E, Wisner KL, Xin Y.

Am J Psychiatry. 2018 Jul 1;175(7):587-589. doi: 10.1176/appi.ajp.2018.18030290. Epub 2018 Apr 16. No abstract available.

PMID:
29656666
28.

Functional movement disorders arising after successful deep brain stimulation.

Breen DP, Rohani M, Moro E, Mayberg HS, Zurowski M, Lozano AM, Fasano A.

Neurology. 2018 May 15;90(20):931-932. doi: 10.1212/WNL.0000000000005530. Epub 2018 Apr 13. No abstract available.

PMID:
29653985
29.

Placebo Effects Across Self-Report, Clinician Rating, and Objective Performance Tasks Among Women With Post-Traumatic Stress Disorder: Investigation of Placebo Response in a Pharmacological Treatment Study of Post-Traumatic Stress Disorder.

Hodgins GE, Blommel JG, Dunlop BW, Iosifescu D, Mathew SJ, Neylan TC, Mayberg HS, Harvey PD.

J Clin Psychopharmacol. 2018 Jun;38(3):200-206. doi: 10.1097/JCP.0000000000000858.

30.

Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank.

Ramirez-Zamora A, Giordano JJ, Gunduz A, Brown P, Sanchez JC, Foote KD, Almeida L, Starr PA, Bronte-Stewart HM, Hu W, McIntyre C, Goodman W, Kumsa D, Grill WM, Walker HC, Johnson MD, Vitek JL, Greene D, Rizzuto DS, Song D, Berger TW, Hampson RE, Deadwyler SA, Hochberg LR, Schiff ND, Stypulkowski P, Worrell G, Tiruvadi V, Mayberg HS, Jimenez-Shahed J, Nanda P, Sheth SA, Gross RE, Lempka SF, Li L, Deeb W, Okun MS.

Front Neurosci. 2018 Jan 24;11:734. doi: 10.3389/fnins.2017.00734. eCollection 2017.

31.

A Shared Vision for Machine Learning in Neuroscience.

Vu MT, Adalı T, Ba D, Buzsáki G, Carlson D, Heller K, Liston C, Rudin C, Sohal VS, Widge AS, Mayberg HS, Sapiro G, Dzirasa K.

J Neurosci. 2018 Feb 14;38(7):1601-1607. doi: 10.1523/JNEUROSCI.0508-17.2018. Epub 2018 Jan 26. Review.

32.

Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders.

Bari AA, Mikell CB, Abosch A, Ben-Haim S, Buchanan RJ, Burton AW, Carcieri S, Cosgrove GR, D'Haese PF, Daskalakis ZJ, Eskandar EN, Gerrard JL, Goodman WK, Greenberg BD, Gross RE, Hamani C, Kiss ZHT, Konrad P, Kopell BH, Krinke L, Langevin JP, Lozano AM, Malone D, Mayberg HS, Miller JP, Patil PG, Peichel D, Petersen EA, Rezai AR, Richardson RM, Riva-Posse P, Sankar T, Schwalb JM, Simpson HB, Slavin K, Stypulkowski PH, Tosteson T, Warnke P, Willie JT, Zaghloul KA, Neimat JS, Pouratian N, Sheth SA.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):886-896. doi: 10.1136/jnnp-2017-317082. Epub 2018 Jan 25.

PMID:
29371415
33.

Follow-up of monotherapy remitters in the PReDICT study: Maintenance treatment outcomes and clinical predictors of recurrence.

Kennedy JC, Dunlop BW, Craighead LW, Nemeroff CB, Mayberg HS, Craighead WE.

J Consult Clin Psychol. 2018 Feb;86(2):189-199. doi: 10.1037/ccp0000279.

34.

Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.

Dunlop BW, Cole SP, Nemeroff CB, Mayberg HS, Craighead WE.

J Affect Disord. 2018 Mar 15;229:111-119. doi: 10.1016/j.jad.2017.12.035. Epub 2017 Dec 27.

35.

Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.

Carrillo-Roa T, Labermaier C, Weber P, Herzog DP, Lareau C, Santarelli S, Wagner KV, Rex-Haffner M, Harbich D, Scharf SH, Nemeroff CB, Dunlop BW, Craighead WE, Mayberg HS, Schmidt MV, Uhr M, Holsboer F, Sillaber I, Binder EB, Müller MB.

PLoS Biol. 2017 Dec 28;15(12):e2002690. doi: 10.1371/journal.pbio.2002690. eCollection 2017 Dec.

36.

Impact of brain shift on subcallosal cingulate deep brain stimulation.

Choi KS, Noecker AM, Riva-Posse P, Rajendra JK, Gross RE, Mayberg HS, McIntyre CC.

Brain Stimul. 2018 Mar - Apr;11(2):445-453. doi: 10.1016/j.brs.2017.12.001. Epub 2017 Dec 6.

37.

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.

O'Connell CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, Debattista C, Carrillo-Roa T, Binder EB, Dunlop BW, Craighead WE, Mayberg HS, Williams LM.

Am J Psychiatry. 2018 Mar 1;175(3):251-261. doi: 10.1176/appi.ajp.2017.17020172. Epub 2017 Dec 15.

38.

Brain-Based Biomarkers for the Treatment of Depression: Evolution of an Idea.

Waters AC, Mayberg HS.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):870-880. doi: 10.1017/S1355617717000881. Review.

PMID:
29198278
39.

Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial.

Holtzheimer PE, Husain MM, Lisanby SH, Taylor SF, Whitworth LA, McClintock S, Slavin KV, Berman J, McKhann GM, Patil PG, Rittberg BR, Abosch A, Pandurangi AK, Holloway KL, Lam RW, Honey CR, Neimat JS, Henderson JM, DeBattista C, Rothschild AJ, Pilitsis JG, Espinoza RT, Petrides G, Mogilner AY, Matthews K, Peichel D, Gross RE, Hamani C, Lozano AM, Mayberg HS.

Lancet Psychiatry. 2017 Nov;4(11):839-849. doi: 10.1016/S2215-0366(17)30371-1. Epub 2017 Oct 4.

PMID:
28988904
40.

The Structure of Personality Disorders within a Depressed Sample: Implications for Personalizing Treatment.

Berg JM, Kennedy JC, Dunlop BW, Ramirez CL, Stewart LM, Nemeroff CB, Mayberg HS, Craighead WE.

Pers Med Psychiatry. 2017 Mar-Apr;1-2:59-64. doi: 10.1016/j.pmip.2016.12.005. Epub 2017 Jan 5.

41.

Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder.

Dunlop BW, Binder EB, Iosifescu D, Mathew SJ, Neylan TC, Pape JC, Carrillo-Roa T, Green C, Kinkead B, Grigoriadis D, Rothbaum BO, Nemeroff CB, Mayberg HS.

Biol Psychiatry. 2017 Dec 15;82(12):866-874. doi: 10.1016/j.biopsych.2017.06.024. Epub 2017 Jul 4.

42.

StimVision Software: Examples and Applications in Subcallosal Cingulate Deep Brain Stimulation for Depression.

Noecker AM, Choi KS, Riva-Posse P, Gross RE, Mayberg HS, McIntyre CC.

Neuromodulation. 2018 Feb;21(2):191-196. doi: 10.1111/ner.12625. Epub 2017 Jun 27.

43.

A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression.

Riva-Posse P, Choi KS, Holtzheimer PE, Crowell AL, Garlow SJ, Rajendra JK, McIntyre CC, Gross RE, Mayberg HS.

Mol Psychiatry. 2018 Apr;23(4):843-849. doi: 10.1038/mp.2017.59. Epub 2017 Apr 11.

44.

Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.

Dunlop BW, Kelley ME, Aponte-Rivera V, Mletzko-Crowe T, Kinkead B, Ritchie JC, Nemeroff CB, Craighead WE, Mayberg HS; PReDICT Team.

Am J Psychiatry. 2017 Jun 1;174(6):546-556. doi: 10.1176/appi.ajp.2016.16050517. Epub 2017 Mar 24.

45.

Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.

Dunlop BW, Rajendra JK, Craighead WE, Kelley ME, McGrath CL, Choi KS, Kinkead B, Nemeroff CB, Mayberg HS.

Am J Psychiatry. 2017 Jun 1;174(6):533-545. doi: 10.1176/appi.ajp.2016.16050518. Epub 2017 Mar 24. Erratum in: Am J Psychiatry. 2017 Jun 1;174(6):604.

46.

Neurocognitive Predictors of Response in Treatment Resistant Depression to Subcallosal Cingulate Gyrus Deep Brain Stimulation.

McInerney SJ, McNeely HE, Geraci J, Giacobbe P, Rizvi SJ, Ceniti AK, Cyriac A, Mayberg HS, Lozano AM, Kennedy SH.

Front Hum Neurosci. 2017 Feb 24;11:74. doi: 10.3389/fnhum.2017.00074. eCollection 2017.

47.

Erratum: Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

Nat Med. 2017 Feb 7;23(2):264. doi: 10.1038/nm0217-264d. No abstract available.

48.

Being open minded about neuromodulation trials: Finding success in our "failures".

Fins JJ, Kubu CS, Mayberg HS, Merkel R, Nuttin B, Schlaepfer TE.

Brain Stimul. 2017 Mar - Apr;10(2):181-186. doi: 10.1016/j.brs.2016.12.012. Epub 2016 Dec 23.

PMID:
28159536
49.

Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.

Deeb W, Giordano JJ, Rossi PJ, Mogilner AY, Gunduz A, Judy JW, Klassen BT, Butson CR, Van Horne C, Deny D, Dougherty DD, Rowell D, Gerhardt GA, Smith GS, Ponce FA, Walker HC, Bronte-Stewart HM, Mayberg HS, Chizeck HJ, Langevin JP, Volkmann J, Ostrem JL, Shute JB, Jimenez-Shahed J, Foote KD, Wagle Shukla A, Rossi MA, Oh M, Pourfar M, Rosenberg PB, Silburn PA, de Hemptine C, Starr PA, Denison T, Akbar U, Grill WM, Okun MS.

Front Integr Neurosci. 2016 Nov 22;10:38. eCollection 2016.

50.

Resting-state connectivity biomarkers define neurophysiological subtypes of depression.

Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A, Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A, Voss HU, Casey BJ, Dubin MJ, Liston C.

Nat Med. 2017 Jan;23(1):28-38. doi: 10.1038/nm.4246. Epub 2016 Dec 5. Erratum in: Nat Med. 2017 Feb 7;23 (2):264.

Supplemental Content

Loading ...
Support Center